Marka sorgulama · Bülten 433

csl vifor

VIFOR (INTERNATIONAL) AG (VIFOR (INTERNATIONAL) LTD.) (VIFOR (INTERNATIONAL) INC.)

Tescilli Başvuru no 2023/103503 · 16 Mart 2023 · vekilsiz başvuru

Süreç

  1. Başvuru 16 Mart 2023
  2. Bültende yayın Resmî Marka Bülteni 433 · 27 Kasım 2023
  3. İtiraz penceresi (2 ay) Son gün 27 Ocak 2024 · kapandı
  4. Tescil Tescil no 2023 103503· Gazete 489 (31 Mayıs 2024)
  5. Yenileme Koruma 10 yıl: yenileme tarihi Mart 2033 (son 6 ay içinde başvurulur).

Resmî süreler ve işlemler için TÜRKPATENT esastır; Nomist bilgilendirme aracıdır.

Bu marka senin mi? Benzer bir başvuru bültene düştüğü gün e-posta alırsın; ilk marka ücretsiz. Web'de ya da uygulamada.

Sınıflar ve kapsam

Mal ve hizmet listesi

Chemical and biological reagents, included in this class; cell cultures and media, included in this class; laboratory and scientific test kits, included in this class; chemical preparations for scientific and industrial use; diagnostic agents and testing means; chemical and biological reagents for non-medical use; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research purposes; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells.Bleaching preparations and other substances for laundry use; Cleaning, polishing, degreasing and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.Pharmaceutical preparations and substances; Blood plasma; blood products, included in this class; products derived from blood and products derived from recombinant DNA technology; vaccines; serums for medical use; antibodies; monoclonal antibodies; test red-blood cells; test kits, included in this class; diagnostic products, included in this class; blood products; medical and veterinary test kits; influenza vaccines; adjuvants and antigens; pharmaceutical preparations and substances for the treatment and prevention of blood or bleeding disorders; blood products, namely, blood plasma, reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums for medical use, namely, antivenom; medicated serums for the treatment of blood or bleeding disorders; test kits, namely, in-vitro diagnostic reagent test kits for use in detecting cell-mediated immune response; pharmaceutical preparations and substances, namely, rhesus factor-D reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or immunoglobulin G subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies; pharmaceutical preparations, namely, reagents for medical or clinical use for the typing and detection of specific blood cells, and the detection of relevant complement components and immunoglobulin subtypes; pharmaceutical or veterinary preparations for use in oncology and diabetes; pharmaceutical or veterinary preparations for use in transplantation, transplantation rejection therapy and transplantation-associated diseases and conditions; pharmaceutical or veterinary preparations comprising stem cells; pharmaceutical or veterinary preparations for use in dialysis-associated diseases, conditions and complications; pharmaceutical or veterinary preparations for use in preserving or improving renal function, for the treatment or prevention of acute kidney injury, for the treatment or prevention of chronic kidney diseases and associated complications; pharmaceutical or veterinary preparations for the treatment or prevention of cardiac, cardiovascular, circulatory, renal system, kidney, cardio-renal, immune system, gastroenterological, gastrointestinal, stomach, dermatological, hematological, bone, respiratory, genetic, allergic, inflammation, infectious, pain, central nervous system, endocrinology, hormonal, muscular, rheumatic, ocular and metabolic diseases and disorders; pharmaceutical and veterinary preparations used as immune system stimulators; pharmaceutical preparations for the treatment or prevention of mineral deficiencies or mineral overload as w … (liste kısaltıldı; tamamı TÜRKPATENT kaydında)

Aynı bültende benzer başvurular

Bülten 433 içindeki 6.485 aynı-sınıf başvuru arasında Nomist'in benzerlik algoritmasına takılan yok.